< Back to all Breaking News
ALT
3/19/2019 07:03am
Altimmune announces additional data from phase 2 NasoVAX study 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
